ClinicalTrials.Veeva

Menu

Coronary Artery Disease: a Case- Control Study

N

Nadia Bouzidi, PhD

Status

Unknown

Conditions

Coronary Artery Disease

Treatments

Biological: Patients
Biological: Healthy subjects

Study type

Observational

Funder types

Other

Identifiers

NCT03075566
1500170

Details and patient eligibility

About

Atherosclerosis is a chronic inflammatory condition, which is associated by the involvement of several pathological events, and alteration in the serum levels of pro- and anti-inflammatory, and lipid markers.

The investigators evaluated the contribution of serum biomarkers levels to the pathogenesis of coronary artery disease, namely their association with risk factors, clinical presentation, extent and severity of atherosclerotic changes accompanying coronary artery disease.

Enrollment

517 estimated patients

Sex

All

Ages

20+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Coronary Artery Disease

Exclusion criteria

  • Severe respiratory disease
  • Liver disease
  • kidney disease
  • Inflammatory diseases (infections, autoimmune disorders, malignancy).

Trial contacts and locations

1

Loading...

Central trial contact

NADIA BOUZIDI, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems